keyword
https://read.qxmd.com/read/38280271/diagnosis-and-management-of-complications-following-pelvic-organ-prolapse-surgery-using-a-synthetic-mesh-french-national-guidelines-for-clinical-practice
#21
REVIEW
Xavier Deffieux, Marie-Aimée Perrouin-Verbe, Sandrine Campagne-Loiseau, Laurence Donon, Amélie Levesque, Jérome Rigaud, Nadja Stivalet, Aurélien Venara, Thibault Thubert, Adrien Vidart, Pierre-Olivier Bosset, Christine Revel-Delhom, Jean-Philippe Lucot, Jean François Hermieu
UNLABELLED: Complications associated with pelvic organ prolapse (POP) surgery using a synthetic non-absorbable mesh are uncommon (<5%) but may be severe and may hugely diminish the quality of life of some women. In drawing up these multidisciplinary clinical practice recommendations, the French National Authority for Health (Haute Autorité de santé, HAS) conducted an exhaustive review of the literature concerning the diagnosis, prevention, and management of complications associated with POP surgery using a synthetic mesh...
March 2024: European Journal of Obstetrics, Gynecology, and Reproductive Biology
https://read.qxmd.com/read/38233610/molecular-analysis-of-metallo-beta-lactamase-producing-pseudomonas-aeruginosa-in-switzerland-2022-2023
#22
JOURNAL ARTICLE
Jacqueline Findlay, Otavio Hallal Ferreira Raro, Laurent Poirel, Patrice Nordmann
OBJECTIVES: The occurrence of metallo-beta-lactamase-producing Pseudomonas aeruginosa (MBL-PA) isolates is increasing globally, including in Switzerland. The aim of this study was to characterise, phenotypically and genotypically, the MBL-PA isolates submitted to the Swiss National Reference Center for Emerging Antibiotic Resistance (NARA) reference laboratory over a 12-month period from July 2022 to July 2023. METHODS: Thirty-nine non-duplicate MBL-PA Isolates were submitted to NARA over the study period from across Switzerland...
January 18, 2024: European Journal of Clinical Microbiology & Infectious Diseases
https://read.qxmd.com/read/38219716/seraph-100-microbind-affinity-blood-filter-does-not-clear-antibiotics-an-analysis-of-antibiotic-concentration-data-from-purify-obs
#23
JOURNAL ARTICLE
Jesse P DeLuca, Daniel J Selig, Pooja Vir, Chau V Vuong, Jeffrey Della-Volpe, Ian M Rivera, Caroline Park, Benjamin Levi, Kathleen P Pratt, Ian J Stewart
INTRODUCTION: Novel hemoperfusion systems are emerging for the treatment of sepsis. These devices can directly remove pathogens, pathogen-associated molecular patterns, cytokines, and other inflammatory markers from circulation. However, significant safety concerns such as potential antibiotic clearance need to be addressed prior to these devices being used in large, clinical studies. METHODS: Prospective, observational study of 34 participants undergoing treatment with the Seraph 100® Microbind Affinity Blood Filter (Seraph 100) device at 6 participating sites in the United States...
January 13, 2024: Blood Purification
https://read.qxmd.com/read/38216844/inoculum-effect-of-ctx-m-15-oxa-48-and-kpc-2-producing-klebsiella-pneumoniae-on-meropenem-and-ceftazidime-avibactam-efficacy
#24
JOURNAL ARTICLE
C Pitart, G Santillana, S Narváez, A Sellarés, I Campo, C Casals-Pascual, A Soriano
The inoculum effect, characterized by diminished antibacterial activity at high bacterial inocula, is studied in the context of beta-lactam and beta-lactamase inhibitor combinations against beta-lactamase-producing Enterobacterales. The inhibition of ESBL + OXA-48 and KPC enzymes, in combination with ceftazidime, demonstrates encouraging results. In this study, 20 Klebsiella pneumoniae isolates were tested with different inocula (1-5 × 105 and 1-5 × 107  cfu/ml) using broth microdilution methods...
January 13, 2024: European Journal of Clinical Microbiology & Infectious Diseases
https://read.qxmd.com/read/38215528/protein-dynamics-underlying-allosteric-regulation
#25
REVIEW
Miro A Astore, Akshada S Pradhan, Erik H Thiede, Sonya M Hanson
Allostery is the mechanism by which information and control are propagated in biomolecules. It regulates ligand binding, chemical reactions, and conformational changes. An increasing level of experimental resolution and control over allosteric mechanisms promises a deeper understanding of the molecular basis for life and powerful new therapeutics. In this review, we survey the literature for an up-to-date biological and theoretical understanding of protein allostery. By delineating five ways in which the energy landscape or the kinetics of a system may change to give rise to allostery, we aim to help the reader grasp its physical origins...
January 11, 2024: Current Opinion in Structural Biology
https://read.qxmd.com/read/38200752/low-occurrence-of-salmonella-spp-in-wild-animals-in-bahia-brazil-population-assessment-and-characterization-in-the-caatinga-and-atlantic-forest-biomes
#26
JOURNAL ARTICLE
Eliege Jullia Eudoxia Dos Santos, Amanda Teixeira Sampaio Lopes, Hllytchaikra Ferraz Fehlberg, Josiane Moreira Rocha, Pedro de Alcântara Brito Júnior, Fernanda Coelho Simas Bernardes, Thaise da Silva Oliveira Costa, Elisa Arcanjo Guilherme, Kristel Myriam De Vleeschouwer, Leonardo de Carvalho Oliveira, Beatris Felipe Rosa, Beatricy Silva de Amorim, Leildo Machado Carilo Filho, Elson Oliveira Rios, Suelen Sanches Ferreira, Dália Dos Prazeres Rodrigues, George Rêgo Albuquerque, Flávia Regina Miranda, Martin Roberto Del Valle Alvarez, Victor Goyannes Dill Orrico, Rachel Passos Rezende, Selene Siqueira da Cunha Nogueira, Lucas Jose Luduverio Pizauro, Bianca Mendes Maciel
Salmonella spp. are known to persist in the environment. Wild animals are believed to act as important reservoirs, with antimicrobial resistance frequently occurring in the environment. However, little is known about the role of the wildlife in Bahia as a reservoir for Salmonella in Brazil. This study aimed to isolate and characterize Salmonella spp. from wildlife in the Atlantic Forest and Caatinga biomes considering indicators such as the animal species, degree of anthropization, sampling area, and feeding habits...
December 20, 2023: Animals: An Open Access Journal From MDPI
https://read.qxmd.com/read/38172444/clinical-recommendations-for-the-inpatient-management-of-lower-respiratory-tract-infections-in-children-and-adolescents-with-severe-neurological-impairment-in-germany
#27
REVIEW
Maximilian David Mauritz, Ulrich von Both, Christian Dohna-Schwake, Christian Gille, Carola Hasan, Johannes Huebner, Markus Hufnagel, Markus Knuf, Johannes G Liese, Hanna Renk, Henriette Rudolph, Ulf Schulze-Sturm, Arne Simon, Florian Stehling, Tobias Tenenbaum, Boris Zernikow
Children and adolescents with severe neurological impairment (SNI) require specialized care due to their complex medical needs. In particular, these patients are often affected by severe and recurrent lower respiratory tract infections (LRTIs). These infections, including viral and bacterial etiology, pose a significant risk to these patients, often resulting in respiratory insufficiency and long-term impairments. Using expert consensus, we developed clinical recommendations on the management of LRTIs in children and adolescents with SNI...
January 3, 2024: European Journal of Pediatrics
https://read.qxmd.com/read/38136771/which-are-the-best-regimens-of-broad-spectrum-beta-lactam-antibiotics-in-burn-patients-a-systematic-review-of-evidence-from-pharmacology-studies
#28
REVIEW
Gianpiero Tebano, Giulia la Martire, Luigi Raumer, Monica Cricca, Davide Melandri, Federico Pea, Francesco Cristini
BACKGROUND: Burn injury causes profound pathophysiological changes in the pharmacokinetic/pharmacodynamic (PK/PD) properties of antibiotics. Infections are among the principal complications after burn injuries, and broad-spectrum beta-lactams are the cornerstone of treatment. The aim of this study was to review the evidence for the best regimens of these antibiotics in the burn patient population. METHODS: We performed a systematic review of evidence available on MEDLINE (from its inception to 2023) of pharmacology studies that focused on the use of 13 broad-spectrum beta-lactams in burn patients...
December 14, 2023: Antibiotics
https://read.qxmd.com/read/38136739/pharmacodynamics-of-doripenem-alone-and-in-combination-with-relebactam-in-an-in-vitro-hollow-fiber-dynamic-model-emergence-of-resistance-of-carbapenemase-producing-klebsiella-pneumoniae-and-the-inoculum-effect
#29
JOURNAL ARTICLE
Elena N Strukova, Maria V Golikova, Svetlana A Dovzhenko, Mikhail B Kobrin, Stephen H Zinner
The emergence of bacteria resistant to beta-lactam/beta-lactamase inhibitor combinations is insufficiently studied, wherein the role of the inoculum effect (IE) in decreased efficacy is unclear. To address these issues, 5-day treatments with doripenem and doripenem/relebactam combination at different ratios of the agents were simulated in a hollow-fiber dynamic model against carbapenemase-producing K. pneumoniae at standard and high inocula. Minimal inhibitory concentrations (MICs) of doripenem alone and in the presence of relebactam at two inocula were determined...
December 7, 2023: Antibiotics
https://read.qxmd.com/read/38136712/antibiotic-guideline-adherence-at-the-emergency-department-a-descriptive-study-from-a-country-with-a-restrictive-antibiotic-policy
#30
JOURNAL ARTICLE
Mariana B Cartuliares, Sara N Søgaard, Flemming S Rosenvinge, Christian B Mogensen, Mathias Amdi Hertz, Helene Skjøt-Arkil
BACKGROUND: Denmark has a low level of antimicrobial resistance (AMR). Patients hospitalized with suspected infection often present with unspecific symptoms. This challenges the physician between using narrow-spectrum antibiotics in accordance with guidelines or broad-spectrum antibiotics to compensate for diagnostic uncertainty. The aim of this study was to investigate adherence to a restrictive antibiotic guideline for the most common infection in emergency departments (EDs), namely community-acquired pneumonia (CAP)...
November 29, 2023: Antibiotics
https://read.qxmd.com/read/38108895/mechanistic-approach-of-effective-combination-of-antibiotics-against-clinical-bacterial-strains-having-new-delhi-metallo-beta-lactamase-variants-and-functional-gain-laboratory-mutant
#31
JOURNAL ARTICLE
Nabeela Farhat, Sameera Mujahid, Asad U Khan
Antimicrobial resistance has emerged as a serious issue for physicians and health-care workers treating infections that could lead to the next pandemic. One of the key resistance mechanisms is beta-lactamases. Although several beta-lactamase inhibitors in combination with antibiotics have been created and are being utilized in clinical settings, resistance to these formulations has also been evolving in the bacterial population due to their distinct targets. In this study we used effective combination of antibiotic as an approach to inhibit multidrug resistance bacteria...
December 18, 2023: Current Microbiology
https://read.qxmd.com/read/38063400/structural-basis-of-metallo-%C3%AE-lactamase-resistance-to-taniborbactam
#32
JOURNAL ARTICLE
Salvador I Drusin, Christophe Le Terrier, Laurent Poirel, Robert A Bonomo, Alejandro J Vila, Diego M Moreno
The design of inhibitors against metallo-β-lactamases (MBLs), the largest family of carbapenemases, has been a strategic goal in designing novel antimicrobial therapies. In this regard, the development of bicyclic boronates, such as taniborbactam (TAN) and xeruborbactam, is a major achievement that may help in overcoming the threat of MBL-producing and carbapenem-resistant Gram-negative pathogens. Of concern, a recent report has shown that New Delhi MBL-9 (NDM-9) escapes the inhibitory action of TAN by a single amino acid substitution with respect to New Delhi MBL-1 (NDM-1), the most widely disseminated MBL...
December 8, 2023: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/38015784/to-lick-one-s-wounds-a-case-of-pasteurella-canis-oralis-osteomyelitis-and-neisseria-animaloris-infection-from-canine-saliva
#33
JOURNAL ARTICLE
Kang Woo Kim, Sovijja Pou, Naveena Sunkara, Margaret Hayes Baker
The complications of wound infections caused by animal related trauma are well known and explored. Of the numerous polymicrobial etiologies, Neisseria animaloris and Pasteurella canis oralis have been reported only in a limited number of cases. This manuscript explores the rare finding of these species in the case of an 83-year-old male with a diabetic foot wound complicated by infection from the saliva of his pet dog. The case highlights the first instance of P. canis oralis without the setting of a penetrating animal bite, emphasizing the vulnerability of open lesions in patients whose comorbidities impair proper wound healing...
December 1, 2023: Rhode Island Medical Journal
https://read.qxmd.com/read/37998801/role-of-a-real-time-tdm-based-expert-clinical-pharmacological-advice-program-in-optimizing-the-early-pharmacokinetic-pharmacodynamic-target-attainment-of-continuous-infusion-beta-lactams-among-orthotopic-liver-transplant-recipients-with-documented-or-suspected
#34
JOURNAL ARTICLE
Milo Gatti, Matteo Rinaldi, Cristiana Laici, Antonio Siniscalchi, Pierluigi Viale, Federico Pea
(1) Objectives: To describe the attainment of optimal pharmacokinetic/pharmacodynamic (PK/PD) targets in orthotopic liver transplant (OLT) recipients treated with continuous infusion (CI) beta-lactams optimized using a real-time therapeutic drug monitoring (TDM)-guided expert clinical pharmacological advice (ECPA) program during the early post-surgical period. (2) Methods: OLT recipients admitted to the post-transplant intensive care unit over the period of July 2021-September 2023, receiving empirical or targeted therapy with CI meropenem, piperacillin-tazobactam, meropenem-vaborbactam, or ceftazidime-avibactam optimized using a real-time TDM-guided ECPA program, were retrospectively retrieved...
November 7, 2023: Antibiotics
https://read.qxmd.com/read/37998793/antimicrobial-activities-of-aztreonam-avibactam-and-comparator-agents-against-enterobacterales-analyzed-by-icu-and-non-icu-wards-infection-sources-and-geographic-regions-atlas-program-2016-2020
#35
JOURNAL ARTICLE
Denis Piérard, Elizabeth D Hermsen, Michal Kantecki, Francis F Arhin
Increasing antimicrobial resistance among multidrug-resistant (MDR), extended-spectrum β-lactamase (ESBL)- and carbapenemase-producing Enterobacterales (CPE), in particular metallo-β-lactamase (MBL)-positive strains, has led to limited treatment options in these isolates. This study evaluated the activity of aztreonam-avibactam (ATM-AVI) and comparator antimicrobials against Enterobacterales isolates and key resistance phenotypes stratified by wards, infection sources and geographic regions as part of the ATLAS program between 2016 and 2020...
November 3, 2023: Antibiotics
https://read.qxmd.com/read/37998792/evaluation-of-antibiotic-resistance-mechanisms-in-gram-negative-bacteria
#36
REVIEW
Anusha Gauba, Khondaker Miraz Rahman
Multidrug-resistant Gram-negative bacterial infections are exponentially increasing, posing one of the most urgent global healthcare and economic threats. Due to the lack of new therapies, the World Health Organization classified these bacterial species as priority pathogens in 2017, known as ESKAPE pathogens. This classification emphasizes the need for urgent research and development of novel targeted therapies. The majority of these priority pathogens are Gram-negative species, which possess a structurally dynamic cell envelope enabling them to resist multiple antibiotics, thereby leading to increased mortality rates...
November 3, 2023: Antibiotics
https://read.qxmd.com/read/37997871/treatment-guidelines-for-multidrug-resistant-gram-negative-microorganisms
#37
REVIEW
R Cantón, P Ruiz-Garbajosa
In recent years, new antimicrobials have been introduced in therapeutics, including new beta-lactam-beta-lactamase inhibitor combinations and cefiderocol in response to therapeutic needs in the face of increasing resistance. There are also different treatment guidelines for infections caused by these microorganisms that have been approved by different professional societies, including those of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Disease Society of America (IDSA) and the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)...
November 2023: Revista Española de Quimioterapia: Publicación Oficial de la Sociedad Española de Quimioterapia
https://read.qxmd.com/read/37942950/antibiotics-with-or-without-rifaximin-for-acute-hepatic-encephalopathy-in-critically-ill-patients-with-cirrhosis-a-double-blind-randomized-controlled-arie-trial
#38
JOURNAL ARTICLE
Anand V Kulkarni, Mahathi Avadhanam, Puja Karandikar, Kalyan Rakam, Anand Gupta, Venu Simhadri, Madhumita Premkumar, Asim Ahmed Zuberi, Deepika Gujjarlapudi, Ramyashri Narendran, Sameer Shaik, Mithun Sharma, Sowmya Iyengar, Manasa Alla, Shantan Venishetty, Duvvur Nageshwar Reddy, Padaki Nagaraja Rao
INTRODUCTION: Critically ill patients with cirrhosis admitted to the intensive care unit (ICU) are usually on broad-spectrum antibiotics because of suspected infection or as a hospital protocol. It is unclear if additional rifaximin has any synergistic effect with broad-spectrum antibiotics in ICU patients with acute overt hepatic encephalopathy (HE). METHODS: In this double-blind trial, patients with overt HE admitted to ICU were randomized to receive antibiotics (ab) alone or antibiotics with rifaximin (ab + r)...
January 1, 2024: American Journal of Gastroenterology
https://read.qxmd.com/read/37909767/molecular-characterization-of-incfii-plasmid-carrying-bla-ndm-5-in-a-salmonella-enterica-serovar-typhimurium-st34-clinical-isolate-in-china
#39
JOURNAL ARTICLE
Shihan Zeng, Yulan Huang, Xiwei Zhang, Liang Fu, Zhaohui Sun, Xiaoyan Li
The detection rate of carbapenem-resistant nontyphoidal Salmonella (NTS) is relatively low. However, carbapenem-sensitive and carbapenem-resistant Salmonella enterica serovar Typhimurium ( S. enterica serovar Typhimurium) were isolated from a clinical outpatient within a span of 10 days, named 1104-65 and 1104-75. We aimed to reveal the mechanism of carbapenem resistance in S. enterica serovar Typhimurium isolates in this case. The resistance phenotype of S. enterica serovar Typhimurium was analyzed by the VITEK-2 Compact equipment and Kirby-Bauer disc diffusion method...
November 1, 2023: MSphere
https://read.qxmd.com/read/37888987/-in-vitro-activity-of-imipenem-relebactam-against-pseudomonas-aeruginosa-isolated-from-patients-with-cystic-fibrosis
#40
JOURNAL ARTICLE
Victor H Ruiz, Andrew Fratoni, David P Nicolau, Joseph L Kuti
Pseudomonas aeruginosa is a common multidrug-resistant pathogen in patients with cystic fibrosis (CF). The in vitro activity of imipenem/relebactam and imipenem was compared with other antipseudomonal antibiotics against 105 isolates from patients with CF from three US hospitals. Imipenem/relebactam, imipenem, meropenem, ceftazidime/avibactam, and ceftolozane/tazobactam susceptibilities were 77%, 55%, 58%, 90%, and 92%, respectively. Relebactam potentiates imipenem against CF P. aeruginosa by fourfold leading imipenem/relebactam to retain susceptibility against most isolates in this cohort...
October 27, 2023: Antimicrobial Agents and Chemotherapy
keyword
keyword
112982
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.